Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.
Read More…
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-508-6533335
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees90
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions
What is Corindus Vascular Robotics' stock symbol?
Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."
How were Corindus Vascular Robotics' earnings last quarter?
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) announced its earnings results on Thursday, August, 8th. The medical equipment provider reported ($0.06) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.01. The medical equipment provider earned $4.58 million during the quarter, compared to analysts' expectations of $4.10 million. View Corindus Vascular Robotics' Earnings History.
When is Corindus Vascular Robotics' next earnings date?
What price target have analysts set for CVRS?
1 Wall Street analysts have issued 1-year target prices for Corindus Vascular Robotics' shares. Their forecasts range from $4.28 to $4.28. On average, they anticipate Corindus Vascular Robotics' stock price to reach $4.28 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Corindus Vascular Robotics.
What is the consensus analysts' recommendation for Corindus Vascular Robotics?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Corindus Vascular Robotics.
Has Corindus Vascular Robotics been receiving favorable news coverage?
News headlines about CVRS stock have trended very negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Corindus Vascular Robotics earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an impact on the company's share price in the immediate future. View News Stories for Corindus Vascular Robotics.
Are investors shorting Corindus Vascular Robotics?
Corindus Vascular Robotics saw a increase in short interest in September. As of September 30th, there was short interest totalling 9,420,000 shares, an increase of 7.2% from the August 30th total of 8,790,000 shares. Based on an average daily volume of 3,300,000 shares, the short-interest ratio is presently 2.9 days. Currently, 7.4% of the shares of the company are short sold. View Corindus Vascular Robotics' Current Options Chain.
Who are some of Corindus Vascular Robotics' key competitors?
Some companies that are related to Corindus Vascular Robotics include Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), InspireMD (NSPR), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).
What other stocks do shareholders of Corindus Vascular Robotics own?
Who are Corindus Vascular Robotics' key executives?
Corindus Vascular Robotics' management team includes the folowing people:
- Mr. Mark J. Toland, CEO, Pres & Director (Age 49)
- Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 49)
- Mr. Douglas Teany, Chief Operating Officer (Age 47)
- Ms. Nora Dutta, Sr. VP of HR
- Dr. J. Aaron Grantham, Chief Medical Officer of Cardiovascular
Who are Corindus Vascular Robotics' major shareholders?
Corindus Vascular Robotics' stock is owned by many different of retail and institutional investors. Top institutional investors include Havens Advisors LLC (0.16%). Company insiders that own Corindus Vascular Robotics stock include Hudson Executive Capital Lp and Louis A Cannon. View Institutional Ownership Trends for Corindus Vascular Robotics.
Which major investors are buying Corindus Vascular Robotics stock?
CVRS stock was purchased by a variety of institutional investors in the last quarter, including Havens Advisors LLC. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Hudson Executive Capital Lp and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.
How do I buy shares of Corindus Vascular Robotics?
Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Corindus Vascular Robotics' stock price today?
One share of CVRS stock can currently be purchased for approximately $4.27.
How big of a company is Corindus Vascular Robotics?
What is Corindus Vascular Robotics' official website?
How can I contact Corindus Vascular Robotics?
Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.
MarketBeat Community Rating for Corindus Vascular Robotics (NYSEAMERICAN CVRS)
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.
